JP2022529823A5 - - Google Patents

Info

Publication number
JP2022529823A5
JP2022529823A5 JP2021562906A JP2021562906A JP2022529823A5 JP 2022529823 A5 JP2022529823 A5 JP 2022529823A5 JP 2021562906 A JP2021562906 A JP 2021562906A JP 2021562906 A JP2021562906 A JP 2021562906A JP 2022529823 A5 JP2022529823 A5 JP 2022529823A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
note
composition according
sodium
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021562906A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529823A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029168 external-priority patent/WO2020219475A1/en
Publication of JP2022529823A publication Critical patent/JP2022529823A/ja
Publication of JP2022529823A5 publication Critical patent/JP2022529823A5/ja
Pending legal-status Critical Current

Links

JP2021562906A 2019-04-22 2020-04-21 ドライアイの治療に使用可能な組成物および方法 Pending JP2022529823A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962836858P 2019-04-22 2019-04-22
US62/836,858 2019-04-22
PCT/US2020/029168 WO2020219475A1 (en) 2019-04-22 2020-04-21 Compositions and methods useable for treatment of dry eye

Publications (2)

Publication Number Publication Date
JP2022529823A JP2022529823A (ja) 2022-06-24
JP2022529823A5 true JP2022529823A5 (cg-RX-API-DMAC7.html) 2023-05-10

Family

ID=72941233

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562906A Pending JP2022529823A (ja) 2019-04-22 2020-04-21 ドライアイの治療に使用可能な組成物および方法

Country Status (9)

Country Link
US (1) US20200345805A1 (cg-RX-API-DMAC7.html)
EP (1) EP3958915A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022529823A (cg-RX-API-DMAC7.html)
KR (1) KR20220003548A (cg-RX-API-DMAC7.html)
CN (1) CN114040783A (cg-RX-API-DMAC7.html)
CA (1) CA3134362A1 (cg-RX-API-DMAC7.html)
IL (1) IL287441A (cg-RX-API-DMAC7.html)
MX (1) MX2021012857A (cg-RX-API-DMAC7.html)
WO (1) WO2020219475A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012011731A2 (pt) * 2009-11-10 2020-08-25 Allegro Pharmaceuticals, Inc. composições e métodos para inibir a adesão celular ou direcionamento dos agentes de diagnóstico ou terapêuticos para os sítios de ligação rgd
US12454549B2 (en) 2017-06-19 2025-10-28 Jenius Pharma, Llc Treatments for diseases and disorders that involve oxidative stress

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3128203B2 (ja) * 1997-02-10 2001-01-29 一男 坪田 分泌腺細胞とリンパ球との接着阻害剤
JP2000336030A (ja) * 1999-03-24 2000-12-05 Taisho Pharmaceut Co Ltd 点眼液
US20070104798A1 (en) * 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
SI1881823T1 (sl) * 2005-05-17 2015-04-30 Sarcode Bioscience Inc. Sestavki in postopki za zdravljenje bolezni oäśesa
US10842669B2 (en) * 2008-11-13 2020-11-24 Gholam A. Peyman Ophthalmic drug delivery method
ITRM20090102U1 (it) * 2009-06-15 2010-12-16 Alfa Intes Ind Terapeutica Splendore S R L Ialuvit preparato per la stabilizzazione del film lacrimale, la cicatrizzazione corneale e il ripristino del contenuto salino della lacrima e osmoprotezione.
BR112012011731A2 (pt) * 2009-11-10 2020-08-25 Allegro Pharmaceuticals, Inc. composições e métodos para inibir a adesão celular ou direcionamento dos agentes de diagnóstico ou terapêuticos para os sítios de ligação rgd
US9011861B2 (en) * 2010-02-25 2015-04-21 Schepens Eye Research Institute Therapeutic compositions for the treatment of dry eye disease
MX2014003993A (es) * 2011-10-12 2014-08-08 Ascendis Pharma Ophthalmology Division As Prevencion y tratamiento de condiciones oculares.
TWI664965B (zh) * 2015-06-22 2019-07-11 新源生物科技股份有限公司 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法
US11433260B2 (en) * 2015-12-21 2022-09-06 Gholam A. Peyman Cancer treatment methods using thermotherapy and/or enhanced immunotherapy
DK3266446T3 (en) * 2016-07-07 2019-02-11 Salvat Lab Sa Eye preparation comprising castor oil and medium chain triglyceride
JP7280619B2 (ja) 2017-06-19 2023-05-24 アレグロ ファーマシューティカルズ エルエルシー ペプチド組成物

Similar Documents

Publication Publication Date Title
JP2022062045A5 (cg-RX-API-DMAC7.html)
JP2024508961A5 (cg-RX-API-DMAC7.html)
FI82605C (fi) Foerfarande foer framstaellning av encellskikt och vaevnader skyddande kondroitinsulfat-natriumhyaluronat -komposition.
JP2969584B2 (ja) 眼の治療用組成物
JP2022040140A5 (cg-RX-API-DMAC7.html)
JP5956735B2 (ja) P2y2受容体作動薬およびヒアルロン酸またはその塩を組み合わせたことを特徴とするドライアイ治療剤
Wais‐Steider et al. Effect of vanadate on gill cilia: switching mechanism in ciliary beat
US5945121A (en) Liposome eye drops
WO2007103111A3 (en) Antiviral drugs for treatment of arenavirus infection
JP2017002035A5 (cg-RX-API-DMAC7.html)
DK0698388T3 (da) Oftalmisk præparat til anvendelse som kunstige tårer
RU2010141542A (ru) Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций
BR112023017725A2 (pt) Solução de tratamento de lentes de contato sem conservantes
KR20150113156A (ko) 나트륨 히알루로네이트 및 카복시메틸셀룰로오스를 포함하는 인공 눈물
JP2024509214A5 (cg-RX-API-DMAC7.html)
JP3748970B2 (ja) ヒアルロン酸ナトリウム含有水溶液
JP2009538287A5 (ja) 低粘度グリコサミノグリカンで構成される組成物及び該組成物の間質性膀胱炎の治療での使用
HU190687B (en) Process for preparing new antithrombotic of polysaccharide base further pharmaceutical compositions containing such substance as active material
KR20110017819A (ko) 소화성 궤양과 십이지장 궤양 치료 및 예방을 위한 히알루론산 혼합물
JP2024512121A5 (cg-RX-API-DMAC7.html)
US3663690A (en) Mucolytic composition and method of treatment of broncho-pulmonary disorders therewith
WO1998032435A1 (en) Liquid eye drop composition
RU2021133821A (ru) Композиции и способы, применимые для лечения синдрома сухого глаза
JP2020524138A (ja) 緑内障治療用点眼組成物
EP1417970B1 (en) Anti-allergic, anti-bacteric and anti-redden compound for eyes